• 1.

    Chiu YW, et al. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 2009; 4:10891096. doi: 10.2215/CJN.00290109

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Ghimire S, et al. Nonadherence to medication therapy in haemodialysis patients: A systematic review. PLoS One 2015; 10:e0144119. doi: 10.1371/journal.pone.0144119

  • 3.

    Manley HJ, et al. Medication-related problems in ambulatory hemodialysis patients: A pooled analysis. Am J Kidney Dis 2005; 46:669680. doi: 10.1053/j.ajkd.2005.07.001

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Gedney N. The impact of medication cost on dialysis patients. Kidney360 2021; 2:922923. doi: 10.34067/KID.0002162021

  • 5.

    Colombijn JMT, et al. Polypharmacy and quality of life among dialysis patients: A qualitative study. Kidney Med 2023; 6:100749. doi: 10.1016/j.xkme.2023.100749

  • 6.

    Tong A, et al. The perspectives of kidney transplant recipients on medicine taking: A systematic review of qualitative studies. Nephrol Dial Transplant 2011; 26:344354. doi: 10.1093/ndt/gfq376

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Eriksen CU, et al. Medication-related experiences of patients with polypharmacy: A systematic review of qualitative studies. BMJ Open 2020; 10:e036158. doi: 10.1136/bmjopen-2019-036158

    • PubMed
    • Search Google Scholar
    • Export Citation

Perspectives of Polypharmacy and Its Effects on Quality of Life by Patients on Dialysis

Jennifer Bergeron Jennifer Bergeron, MD, is an assistant professor of medicine and assistant program director in the Division of Nephrology, West Virginia University School of Medicine, Morgantown.

Search for other papers by Jennifer Bergeron in
Current site
Google Scholar
PubMed
Close
Restricted access
Save